O
IART icon

OppenheimerFunds’s Integra LifeSciences IART Stock Holding History

OppenheimerFunds’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$362K Sell
6,502
-399,417
-98% -$20.3M ﹤0.01% 1486
2018
Q4 		$18.3M Sell
405,919
-295,639
-42% -$16.2M 0.03% 537
2018
Q3 		$46.2M Buy
701,558
+97,243
+16% +$6.04M 0.05% 354
2018
Q2 		$38.9M Buy
604,315
+142,321
+31% +$8.81M 0.05% 390
2018
Q1 		$25.6M Buy
461,994
+34,167
+8% +$1.79M 0.03% 501
2017
Q4 		$20.5M Sell
427,827
-220,673
-34% -$10.8M 0.02% 573
2017
Q3 		$32.7M Buy
648,500
+111,393
+21% +$5.72M 0.04% 417
2017
Q2 		$29.3M Buy
537,107
+72,108
+16% +$3.44M 0.04% 435
2017
Q1 		$19.6M Sell
464,999
-138,575
-23% -$5.92M 0.02% 588
2016
Q4 		$25.9M Sell
603,574
-239,228
-28% -$9.72M 0.03% 497
2016
Q3 		$34.8M Buy
842,802
+54,046
+7% +$2.26M 0.04% 416
2016
Q2 		$31.5M Buy
788,756
+42,852
+6% +$1.54M 0.04% 436
2016
Q1 		$25.1M Sell
745,904
-24,042
-3% -$749K 0.03% 491
2015
Q4 		$26.1M Buy
769,946
+332,406
+76% +$10.4M 0.03% 490
2015
Q3 		$13M Buy
+437,540
New +$13.7M 0.02% 662
2015
Q2 		– Sell
-851,463
Closed -$21.5M – 946
2015
Q1 		$21.5M Buy
851,463
+21,859
+3% +$517K 0.02% 577
2014
Q4 		$18.4M Buy
829,604
+97,204
+13% +$1.97M 0.02% 606
2014
Q3 		$14.9M Sell
732,400
-1,062
-0.1% -$21.1K 0.02% 645
2014
Q2 		$14.1M Buy
733,462
+16,768
+2% +$312K 0.02% 681
2014
Q1 		$13.5M Buy
+716,694
New +$13.8M 0.02% 699

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds's IART Position: Q1 2019 in Review

OppenheimerFunds reduced its Integra LifeSciences (IART) stake by 98% in Q1 2019, selling an estimated $20.3M and leaving 6,502 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

OppenheimerFunds first reported a position in IART in Q1 2014 and has held it in 20 quarters since. The position peaked at $46.2M in Q3 2018. 259 funds tracked by Wall St. Rank hold IART as of Q1 2019.

  • OppenheimerFunds held 6,502 shares of Integra LifeSciences worth $362K as of Q1 2019.
  • OppenheimerFunds sold 399,417 Integra LifeSciences shares in Q1 2019, an estimated $20.3M.
  • Integra LifeSciences made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1486 holding.
  • OppenheimerFunds first reported a position in Integra LifeSciences in Q1 2014 and has held it in 20 quarters since.
  • OppenheimerFunds's Integra LifeSciences position peaked at $46.2M in Q3 2018.
  • 259 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.